These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 11113270)

  • 1. Mild hyperhomocysteinemia and fibrinolytic factors in patients with history of venous thromboembolism.
    Bozic M; Stegnar M; Fermo I; Ritonja A; Peternel P; Stare J; D'Angelo A
    Thromb Res; 2000 Nov; 100(4):271-8. PubMed ID: 11113270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interrelation of hyperhomocysteinemia and inherited risk factors for venous thromboembolism. Results from the E.D.I.TH. study: a hospital-based case-control study.
    Oger E; Lacut K; Le Gal G; Couturaud F; Abalain JH; Mercier B; Mottier D;
    Thromb Res; 2007; 120(2):207-14. PubMed ID: 17126889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hyperhomocysteinemia prevalence among patients with venous thromboembolism.
    Köktürk N; Kanbay A; Aydoğdu M; Özyılmaz E; Bukan N; Ekim N
    Clin Appl Thromb Hemost; 2011 Oct; 17(5):487-93. PubMed ID: 20699251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prospective study of fibrinolytic markers and venous thromboembolism.
    Folsom AR; Cushman M; Heckbert SR; Rosamond WD; Aleksic N
    J Clin Epidemiol; 2003 Jun; 56(6):598-603. PubMed ID: 12873656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High cysteine levels in renal transplant recipients: relationship with hyperhomocysteinemia and 5,10-MTHFR polymorphism.
    Marcucci R; Fedi S; Brunelli T; Pepe G; Prisco D; Rosati A; Zanazzi M; Bertoni E; Abbate R; Salvadori M
    Transplantation; 2001 Mar; 71(6):746-51. PubMed ID: 11330536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hyperhomocyst(e)inemia and the increased risk of venous thromboembolism: more evidence from a case-control study.
    Langman LJ; Ray JG; Evrovski J; Yeo E; Cole DE
    Arch Intern Med; 2000 Apr; 160(7):961-4. PubMed ID: 10761961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mild hyperhomocysteinemia is associated with a decreased fibrinolytic activity in patients after ST-elevation myocardial infarction.
    Speidl WS; Nikfardjam M; Niessner A; Zeiner A; Jordanova N; Zorn G; Maurer G; Schreiber W; Wojta J; Huber K
    Thromb Res; 2007; 119(3):331-6. PubMed ID: 16616324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperhomocysteinemia and venous thromboembolism: a risk factor more prevalent in the elderly and in idiopathic cases.
    Hainaut P; Jaumotte C; Verhelst D; Wallemacq P; Gala JL; Lavenne E; Heusterspreute M; Zech F; Moriau M
    Thromb Res; 2002 Apr; 106(2):121-5. PubMed ID: 12182910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
    Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
    Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hyperhomocysteinaemia, hyperlipidaemia and risk of venous thromboembolism in Shiraz.
    Zamani A; Omrani GR; Lankarani KB
    East Mediterr Health J; 2003; 9(5-6):935-43. PubMed ID: 16450523
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
    Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
    J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperhomocysteinemia is a risk factor of recurrent venous thromboembolism.
    Eichinger S; Stümpflen A; Hirschl M; Bialonczyk C; Herkner K; Stain M; Schneider B; Pabinger I; Lechner K; Kyrle PA
    Thromb Haemost; 1998 Oct; 80(4):566-9. PubMed ID: 9798970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential associations between lipid-lowering drugs, statins and fibrates, and venous thromboembolism: role of drug induced homocysteinemia?
    Lacut K; Le Gal G; Abalain JH; Mottier D; Oger E
    Thromb Res; 2008; 122(3):314-9. PubMed ID: 18048086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hyperhomocysteinemia but not the C677T mutation of methylenetetrahydrofolate reductase is an independent risk determinant of carotid wall thickening. The Perth Carotid Ultrasound Disease Assessment Study (CUDAS).
    McQuillan BM; Beilby JP; Nidorf M; Thompson PL; Hung J
    Circulation; 1999 May; 99(18):2383-8. PubMed ID: 10318658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinolytic variables in patients with recurrent venous thrombosis: a prospective cohort study.
    Crowther MA; Roberts J; Roberts R; Johnston M; Stevens P; Skingley P; Patrassi GM; Sartori MT; Hirsh J; Prandoni P; Weitz JI; Gent M; Ginsberg JS
    Thromb Haemost; 2001 Mar; 85(3):390-4. PubMed ID: 11307802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hyperhomocysteinemia in vascular disease: comparative study of thrombotic venous disease vis-à-vis occlusive arterial disease.
    Bhargava S; Parakh R; Manocha A; Ali A; Srivastava LM
    Vascular; 2007; 15(3):149-53. PubMed ID: 17573020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine in inflammatory bowel disease: a risk factor for thromboembolic complications?
    Oldenburg B; Fijnheer R; van der Griend R; vanBerge-Henegouwen GP; Koningsberger JC
    Am J Gastroenterol; 2000 Oct; 95(10):2825-30. PubMed ID: 11051355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma homocysteine cutoff values for venous thrombosis.
    Castañon MM; Lauricella AM; Kordich L; Quintana I
    Clin Chem Lab Med; 2007; 45(2):232-6. PubMed ID: 17311514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased fasting total homocysteine plasma levels as a risk factor for thromboembolism in children.
    Kosch A; Koch HG; Heinecke A; Kurnik K; Heller C; Nowak-Göttl U;
    Thromb Haemost; 2004 Feb; 91(2):308-14. PubMed ID: 14961159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of hyperhomocysteinemia as a risk factor for venous thromboembolism in a Taiwanese population. A case-control study.
    Hsu TS; Hsu LA; Chang CJ; Sun CF; Ko YL; Kuo CT; Chiang CW; Lee YS
    Thromb Res; 2001 Jun; 102(5):387-95. PubMed ID: 11395124
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.